Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt

Characteristics and Outcome of COVID-19 Among Egyptian Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04339322

Acronym

COVID-19

Enrollment

200

Registered

2020-04-09

Start date

2020-05-01

Completion date

2020-07-30

Last updated

2020-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Characteristics Diseases, Outcome, Fatal

Keywords

Covid-19, characteristics, Outcome, Egypt

Brief summary

The World Health Organization (WHO) has recently declared coronavirus disease 2019 (Covid-19) a public health emergency of international concern. Egypt is one of the countries that has been infected by Covid-19. The characteristics of clinical presentation, laboratory and radiological data are not yet studied. Outcomes of covid-19 in Egypt also have not been described yet.

Detailed description

Patients admitted to Assiut University hospital, Al Rajhi liver hospital and other covid-19 Quarantine hospitals will be included. The characteristics of patients will be described such as demographic data; age, sex,history of contact to COVID-19 patients or traveling abroad and their clinical manifestation such as fever,cough,shortness of breath, sore throat, diarrhea. Laboratory data will also be included such as blood picture,D-Dimer, serum ferritin, creatinine, liver enzymes, oxygen saturation and covid-19 polymerase chain reaction (PCR). Radiological data will be described as regarding chest X-ray and/or computed tomography. Patients will be followed until complications, improvement, transfer to another hospital or death and their outcome will be described.

Interventions

OTHERFollow up

Follow up to assess the outcome until complications, improvement, death or being transferred to another quarantine hospital.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* Patients with diagnosis of Covid-19 .

Exclusion criteria

* Patients refuse to participate in the study

Design outcomes

Primary

Measure	Time frame	Description
Demographics of Coronavirus Disease 2019 (COVID-19) in the cohort group	2 months	Sheet recording age, sex, co-morbidity,history of contact
Clinical manifestations of Coronavirus Disease 2019 (COVID-19)	2 month	Sheet recording symptoms and signs
Laboratory data of included Coronavirus Disease 2019 (COVID-19) cohort	2 months	blood picture,D-Dimer, creatinine, liver enzymes
Radiological features of Coronavirus Disease 2019 (COVID-19) cohort	2 month	Chest x-ray and/or Computed tomography

Secondary

Measure	Time frame	Description
outcomes of Coronavirus Disease 2019 (COVID-19) infection in the cohort group	1 week	Data recording of the outcomes of treatment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026